Novel discriminative stimulus effects of TPA023B, subtype-selective γ-aminobutyric-acid_A/benzodiazepine modulator: Comparisons with zolpidem, lorazepam, and TPA023

Chemical Compounds

• Zolpidem 76%
• Lorazepam 73%
• Benzodiazepine 55%
• Anxiolytic Agent 44%
• Partial Agonist 41%
• Hypnotic 25%
• Dose 24%
• Antagonist 14%
• Binding Site 11%
• Drug 8%
• Reduction 7%
• Ligand 6%

Medicine & Life Sciences

• Zolpidem 68%
• Lorazepam 64%
• Benzodiazepines 48%
• Anti-Anxiety Agents 17%
• GABA-A Receptors 17%
• Hypnotics and Sedatives 8%
• Binding Sites 6%
• Ligands 5%
• In Vitro Techniques 3%
• Pharmaceutical Preparations 3%